Citations

Mayo Clinic

Showing 10 of 108523 citations.

Traumatic anterior cervical pseudomeningocele causing intracranial hypotension successfully treated with blood patch: case report
Takahashi, Edwin A. , Eckel, Laurence J. , Schwartz, Kara M., Diehn, Felix E. , Hunt, Christopher H. , Daniels, David J. , Takahashi, Edwin A

Journal of Neurosurgery: Spine | May 29, 2015 | Volume: 23 | Issue: 3 | Pages: 303-305

10.3171/2014.12.spine14735 | PMID 26023899 Get It

Cervical pseudomeningocele is a rare complication of trauma. It develops when an extradural collection of cerebrospinal fluid (CSF) develops after a dural breach. The authors present the unusual case of a 33-year-old man with progressive headache, neck pain, mental status changes, and cardiopulmonary instability after polytrauma sustained from a motorcycle-versus-deer collision, without improvement during a 5-day hospitalization. Magnetic resonance imaging revealed a collection of CSF anterior to the cervical thecal sac compatible with an anterior cervical pseudomeningocele. A nontargeted epidural blood patch was performed with subsequent resolution of the patient's symptoms. Anterior cervical pseudomeningoceles are usually asymptomatic; however, these lesions can cause orthostatic headaches, neck pain, and cardiopulmonary compromise, as it did in the featured patient. Pseudomeningoceles should be included in the differential diagnosis for posttrauma patients with progressive neurological decline or postural headache, and blood patch may be an effective minimally invasive treatment.
Electronic Cigarettes and Cardiovascular Risk: Hype Or Up in smoke?
Nelluri, B.K., Murphy, Katie , Mookadam, Farouk, Nelluri, Bhargava Krishna, Mookadam, Farouk

Future Cardiology | May 29, 2015 | Volume: 11 | Issue: 3 | Pages: 271-273

10.2217/fca.15.13 | PMID 26021631 Get It

Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer’s Disease
Li, Gongbo , Kim, Chaeyoung, Kim, Jaekwang , Yoon, Hyejin , Zhou, Huadong , Kim, Jungsu, Kim, Jungsu, Kim, Jungsu , Kim, Jungsu, Kim, Jungsu, Kim, Jungsu

Journal of Alzheimer's Disease | May 29, 2015 | Volume: 46 | Issue: 1 | Pages: 109-122

10.3233/jad-150024 | PMID 25720399 Get It

Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus
Joo, Kwan Joong , Zhang, Xiaoliu , Li, Hongtao , Lerner, Seth P.

Bladder Cancer | May 29, 2015 | Volume: 1 | Issue: 1 | Pages: 81-90

10.3233/blc-150013 | PMID 30561438 Get It

Purpose: Despite recent improvements, resistance to traditional immunotherapy or chemotherapy is still common in patients with bladder cancer. We constructed an oncolytic virus from herpes simplex virus type II (HSV-2), which selectively targets tumor cells with an activated Ras signaling pathway. We evaluated the antitumor effect of this oncolytic HSV-2 (FusOn-H2) against bladder cancer, and compared with that of a first generation oncolytic virus derived from HSV-1 (Baco-1). Materials and methods: We established bladder tumor at the orthotopic site in C3H/He mice using the MBT-2 cells. Baco-1 or FusOn-H2 was instilled into the bladder through the urethra respectively. Tumor volume and weight were recorded by the end of the experiment. Animal spleens were also collected to determine if any anti-tumor immunity was elicited during virotherapy in this syngeneic bladder cancer model. Results: Two instillations of the oncolytic HSVs into bladder of tumor-bearing mice almost completely eradicated the tumor in majority of tumor bearing mice. The results of tumor-specific cytotoxic T lymphocyte activity assay showed that tumor destruction by oncolytic viruses in vivo, especially by the FusOn-H2, induced potent anti-tumor immune responses. Conclusion: Oncolytic virus derived from HSV-2 has potent anti-tumor activity against bladder cancer. Oncolytic effect of this virus in vivo induces tumor specific cellular immunity that further enhances the overall anti-tumor activity. Translating this novel virotherapy into the clinic could present an alternative intravesical therapy strategy for patients with bladder cancer.
Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
Thompson, Pamela, Lakshminarayanan, Vani , Supekar, Nitin T. , Cohen, Peter A. , Wolfert, Margreet A. , Gendler, Sandra , Boons, Geert‐Jan , Bradley, Judy Martina

Chemical Communications | May 29, 2015 | Volume: 51 | Issue: 50 | Pages: 10214-10217

10.1039/c5cc02199e | PMID 26022217 Get It

A strategically designed sialyl-Tn building block was synthesized in a stereospecific manner for the rapid linear construction of a glycolipopeptide cancer vaccine.
Atrial Fibrillation Pathophysiology and Prognosis
Siontis, Konstantinos C. , Geske, Jeffrey B. , Gersh, Bernard J. , Geske, Jeffrey B

Circulation: Cardiovascular Imaging | May 29, 2015 | Volume: 8 | Issue: 6 | Pages: No page available

10.1161/circimaging.115.003020 | PMID 26022381 Get It

Draft Genome Sequences of 24 Microbial Strains Assembled from Direct Sequencing from 4 Stool Samples
Jeraldo, Patricio , Hernandez, Alvaro G. , White, Bryan A. , O’Brien, Daniel R. , Ahlquist, David A. , Boardman, Lisa, Ahlquist, David, Boardman, Lisa, Chia, Nicholas , Jeraldo, Patricio R

Genome Announcements | May 29, 2015 | Volume: 3 | Issue: 3 | Pages: No page available

10.1128/genomea.00526-15 | PMID 26021920 Get It

ABSTRACT The ability to assemble genomes from metagenomic sequencing avoids the need for culture and any associated culture biases. We assembled 24 essentially complete draft genomes from metagenomic pair-end and size-selected mate pair sequencing from 4 stool samples, 2 from subjects diagnosed with colorectal cancer and 2 from healthy controls.
A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis
Xu, Xiaohua , Đenić, Aleksandar , Jordan, Luke R. , Wittenberg, Nathan J. , Warrington, Arthur E. , Wootla, Bharath , Papke, Louisa, Zoecklein, Laurie, Yoo, Daehan , Pease, Larry R. , Rodriguez, Moses , Papke, Louisa M, Zoecklein, Laurie J, Shaver, Jonah , Oh, Sang‐Hyun , Oh, Sang-Hyun , Wootla, Bharath , Denic, Aleksandar , Rodriguez, Moses

Disease Models & Mechanisms | May 29, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1242/dmm.020727 | PMID 26035393 Get It

Amyotrophic lateral sclerosis (ALS) is a devastating, fatal neurologic disease that primarily affects spinal cord anterior horn cells and their axons for which there is no treatment. Here we report the use of a recombinant natural human IgM that binds to the surface of neurons and supports neurite extension, rHIgM12, as a therapeutic strategy in murine models of human ALS. A single 200 µg intraperitoneal dose of rHIgM12 increases survival in two independent genetic-based mutant SOD1 mouse strains (SOD1G86R and SOD1G93A) by 8 and 10 days, delays the onset of neurologic deficits by 16 days, delays the onset of weight loss by 5 days, and preserves spinal cord axons and anterior horn neurons. Immuno-overlay of thin layer chromatography and surface plasmon resonance show that rHIgM12 binds with high affinity to complex gangliosides GD1a and GT1b. Addition of rHIgM12 to neurons in culture increases α-tubulin tyrosination levels, suggesting an alteration of microtubule dynamics. We previously reported that a single peripheral dose of rHIgM12 preserved neurologic function in a murine model of demyelination with axon loss. Because rHIgM12 improves three different models of neurologic disease, we propose the IgM may act late in the cascade of neuronal stress and/or death by a broad mechanism.
Aging is associated with altered vasodilator kinetics in dynamically contracting muscle: role of nitric oxide
Casey, Darren P. , Ranadive, Sushant M. , Joyner, Michael J. , Joyner, Michael J , Ranadive, Sushant

Journal of Applied Physiology | May 28, 2015 | Volume: 119 | Issue: 3 | Pages: 232-241

10.1152/japplphysiol.00787.2014 | PMID 26023230 Get It

We tested the hypothesis that aging would be associated with slowed vasodilator kinetics in contracting muscle in part due to a reduced nitric oxide (NO) bioavailability. Young ( n = 10; 24 ± 2 yr) and older ( n = 10; 67 ± 2 yr) adults performed rhythmic forearm exercise (4 min each) at 10, 20, and 30% of max during saline infusion (control) and NO synthase (NOS) inhibition. Brachial artery diameter and velocities were measured using Doppler ultrasound. Forearm vascular conductance (FVC) was calculated for each duty cycle (1 s contraction/2 s relaxation) from forearm blood flow (FBF; ml/min) and blood pressure (mmHg) and fit with a monoexponential model. The main parameters derived from the model were the amplitude of the FBF and FVC response and the number of duty cycles for FBF and FVC to change 63% of the steady-state amplitude (τFBF and τFVC). Under control conditions 1) the amplitude of the FVC response at 30% maximal voluntary contraction (MVC) was lower in older compared with young adults (319 ± 33 vs. 462 ± 52 ml·min−1·100 mmHg−1; P < 0.05) and 2) τFVC was slower in older (10 ± 1, 13 ± 1, and 15 ± 1 duty cycles) compared with young (6 ± 1, 9 ± 1, and 11 ± 1 duty cycles) adults at all intensities ( P < 0.05). In young adults, NOS inhibition blunted the amplitude of the FVC response at 30% MVC and prolonged the τFVC at all intensities (10 ± 2, 12 ± 1, and 16 ± 2 duty cycles; P < 0.05), whereas it did not change in older adults. Our data indicate that the blood flow and vasodilator kinetics in exercising muscle are altered with aging possibly due to blunted NO signaling.
New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
Yab, Tracy C. , Sun, Zhifu , Middha, Sumit , Baheti, Saurabh , Zou, Hongzhi , Smyrk, Thomas C. , Boardman, Lisa A., Petersen, Gloria M. , Ahlquist, David A. , Kisiel, John B. , Raimondo, Massimo , Mahoney, Douglas W. , Taylor, William R. , Boardman, Lisa A., Sun, Zhifu

Clinical Cancer Research | May 28, 2015 | Volume: 21 | Issue: 19 | Pages: 4473-4481

10.1158/1078-0432.ccr-14-2469 | PMID 26023084 Get It

Abstract Purpose: Discriminant markers for pancreatic cancer detection are needed. We sought to identify and validate methylated DNA markers for pancreatic cancer using next-generation sequencing unbiased by known targets. Experimental Design: At a referral center, we conducted four sequential case–control studies: discovery, technical validation, biologic validation, and clinical piloting. Candidate markers were identified using variance-inflated logistic regression on reduced-representation bisulfite DNA sequencing results from matched pancreatic cancers, benign pancreas, and normal colon tissues. Markers were validated technically on replicate discovery study DNA and biologically on independent, matched, blinded tissues by methylation-specific PCR. Clinical testing of six methylation candidates and mutant KRAS was performed on secretin-stimulated pancreatic juice samples from 61 patients with pancreatic cancer, 22 with chronic pancreatitis, and 19 with normal pancreas on endoscopic ultrasound. Areas under receiver-operating characteristics curves (AUC) for markers were calculated. Results: Sequencing identified &gt;500 differentially hyper-methylated regions. On independent tissues, AUC on 19 selected markers ranged between 0.73 and 0.97. Pancreatic juice AUC values for CD1D, KCNK12, CLEC11A, NDRG4, IKZF1, PKRCB, and KRAS were 0.92*, 0.88, 0.85, 0.85, 0.84, 0.83, and 0.75, respectively, for pancreatic cancer compared with normal pancreas and 0.92*, 0.73, 0.76, 0.85*, 0.73, 0.77, and 0.62 for pancreatic cancer compared with chronic pancreatitis (*, P = 0.001 vs. KRAS). Conclusions: We identified and validated novel DNA methylation markers strongly associated with pancreatic cancer. On pilot testing in pancreatic juice, best markers (especially CD1D) highly discriminated pancreatic cases from controls. Clin Cancer Res; 21(19); 4473–81. ©2015 AACR.